Stockreport

AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... [Yahoo! Finance]

AbCellera Biologics Inc. - Common Shares  (ABCL) 
PDF Sales and Marketing Expenses: About $3 million, a small reduction from last year. General and Administration Expenses: Approximately $19 million, up from $14 million [Read more]